21 October 2025 : Clinical Research
Comparative Outcomes of Microwave Ablation Versus Surgery for Papillary Thyroid Microcarcinoma
Gang Hu AE 1, LiHua Xu B 1, WanJu Wang C 1*, Rui Zhou BF 2DOI: 10.12659/MSM.948460
Med Sci Monit 2025; 31:e948460
Table 3 Comparison of thyroid hormone levels before and after microwave ablation treatment of papillary thyroid microcarcinoma.
| Time | FT3 (pmol/L) | FT4 (pmol/L) | TSH (μIU/ml) |
|---|---|---|---|
| Baseline | 5.16 (4.95, 5.22) | 13.93 (12.16, 14.39) | 2.13 (2.00, 2.64) |
| After ablation | |||
| 1 Month | 5.12 (4.91, 5.19) | 13.67 (12.06, 14.35) | 2.04 (1.91, 2.51) |
| 3 Month | 5.14 (4.91, 5.20) | 13.72 (12.10, 14.37) | 2.08 (1.94, 2.58) |
| 6 Month | 5.15 (4.92, 5.21) | 13.90 (12.13, 14.38) | 2.12 (2.00, 2.62) |
| 9 Month | 5.17 (4.94, 5.21) | 13.94 (12.16, 14.40) | 2.14 (2.02, 2.66) |
| 12 Month | 5.17 (4.96, 5.22) | 13.93 (12.17, 14.41) | 2.14 (2.01, 2.64) |
| FT3 – free T3; FT4 – free T4; TSH – thyroid stimulating hormone. | |||